| Brian Wienzek, RPH | |
|
23 S Perimeter Rd, Londonderry, NH 03053-2041 | |
| (603) 625-6406 | |
| (603) 641-6754 |
| Full Name | Brian Wienzek |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 23 S Perimeter Rd, Londonderry, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568666873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | R1198 (New Hampshire) | Primary |
| 183500000X | Pharmacist | 033-0002984 (Vermont) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Brian Wienzek, RPH 118 Donahue Dr, Manchester, NH 03103-6107 Ph: (603) 644-1929 | Brian Wienzek, RPH 23 S Perimeter Rd, Londonderry, NH 03053-2041 Ph: (603) 625-6406 |
News Archive
Silver nanoparticles cause more damage to testicular cells than titanium dioxide nanoparticles, according to a recent study by the Norwegian Institute of Public Health. However, the use of both types may affect testicular cells with possible consequences for fertility.
A study of older adults with diabetes mellitus (DM) suggests a bidirectional association between hypoglycemic (low blood glucose) events and dementia, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
Working with mice, Johns Hopkins researchers say they have figured out how stem cells found in a part of the brain responsible for learning, memory and mood regulation decide to remain dormant or create new brain cells. Apparently, the stem cells "listen in" on the chemical communication among nearby neurons to get an idea about what is stressing the system and when they need to act.
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
AxoGlia Therapeutics SA, a biopharmaceutical company which drives the development of innovative neural stem/progenitor cell differentiation and neuroprotective therapeutics, today announced that it has been awarded a Rapid Response Innovative Award from The Michael J. Fox Foundation, for a project that is performed in collaboration with the Luxembourg Centre for Systems Biomedicine (LCSB).
› Verified 3 days ago
Dr. Melissa Mears, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Hampton Dr, Londonderry, NH 03053 Phone: 603-421-0076 | |
Megan Cleary, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 177 Mammoth Rd, Londonderry, NH 03053 Phone: 603-432-2657 | |
Erica L Lussier, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Hampton Dr, Londonderry, NH 03053 Phone: 603-421-0076 | |
Mr. Anthony Joseph Gallo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Rt 102, Old Orchard View Dr, Londonderry, NH 03053 Phone: 603-432-6362 Fax: 603-437-4531 | |
Mrs. Linda Almquist Coate, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 Nashua Rd, Londonderry, NH 03053 Phone: 603-432-5897 | |
Allison Paradis, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 177 Mammoth Rd, Londonderry, NH 03053 Phone: 603-432-2657 | |
Mr. Daniel D'alessandro, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 Nashua Rd, Londonderry, NH 03053 Phone: 603-432-5897 Fax: 603-432-1167 |